Citation Impact
Citing Papers
Characterizing and explaining the impact of disease-associated mutations in proteins without known structures or structural homologs
2022 StandoutNobel
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
2017 Standout
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
2012 StandoutScience
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
MDS research criteria for prodromal Parkinson's disease
2015
Circadian clocks and neurodegenerative diseases: time to aggregate?
2013
Plasma β-amyloid in Alzheimer’s disease and vascular disease
2016 StandoutNobel
The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis
2017
Microbiota in health and diseases
2022 Standout
Posterior cortical atrophy
2012
Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen
2009 Standout
Exploring the Pathogenesis of Alzheimer Disease in Basal Forebrain Cholinergic Neurons: Converging Insights From Alternative Hypotheses
2019
Engineering precision nanoparticles for drug delivery
2020 Standout
A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
2015
Parkinson disease
2017 Standout
TREM2 in Neurodegenerative Diseases
2017
Limbic encephalitis: A cause of temporal lobe epilepsy with onset in adult life
2007
Parkinson's disease
2021 Standout
Brain aging, Alzheimer's disease, and mitochondria
2011
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Neurofilament light chain as a biomarker in neurological disorders
2019 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
2018
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells
2010 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
2014
Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders
2006
Lysosomal cell death mechanisms in aging
2016
The molecular machinery of regulated cell death
2019 Standout
Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99)
2019
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
Tau in physiology and pathology
2015 Standout
Amyotrophic lateral sclerosis: A 40-year personal perspective
2009
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Hierarchical feature representation and multimodal fusion with deep learning for AD/MCI diagnosis
2014 Standout
Epidemiology of Parkinson’s disease
2017 Standout
Single App knock-in mouse models of Alzheimer's disease
2014
Structural Imaging in Parkinson’s Disease: New Developments
2019
Assessment of α-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study
2016
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
2007 Standout
Parkinson's disease
2015 Standout
Gut microbiome alterations in Alzheimer’s disease
2017 Standout
Different Brain Regions are Infected with Fungi in Alzheimer’s Disease
2015
The neuropathology of genetic Parkinson's disease
2012
Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions
2016
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia
2010 Standout
Alzheimer's disease
2016 Standout
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series
2010 Standout
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
2010 Standout
Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
2015
Oxidative stress and mitochondrial dysfunction in Alzheimer's disease
2013 Standout
Non-motor features of Parkinson disease
2017 Standout
Processing of Mutant β-Amyloid Precursor Protein and the Clinicopathological Features of Familial Alzheimer’s Disease
2018
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates
2005
The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies
2018
Biomarkers for Alzheimer Disease: Classical and Novel Candidates’ Review
2017
Challenges of modifying disease progression in prediagnostic Parkinson's disease
2016
Amyloid biomarkers in Alzheimer's disease
2015
Reassessment of Exosome Composition
2019 Standout
Down syndrome
2020 Standout
Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
2018
Single-cell transcriptomic analysis of Alzheimer’s disease
2019 StandoutNature
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
The amyloid hypothesis of Alzheimer's disease at 25 years
2016 Standout
Criteria for the diagnosis of corticobasal degeneration
2013 Standout
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD
2015
Age-Associated mRNA and miRNA Expression Changes in the Blood-Brain Barrier
2019 StandoutNobel
Down Syndrome
2020 Standout
Alzheimer's disease
2017 Standout
Neuroinflammation in Alzheimer's disease: Current evidence and future directions
2016
Alzheimer's disease first symptoms are age dependent: Evidence from the NACC dataset
2015
Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
2015
The neuropathological diagnosis of Alzheimer’s disease
2019 Standout
The Concept of Prodromal Parkinson’s Disease
2015
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Qualitative changes in human γ-secretase underlie familial Alzheimer’s disease
2015
Multiple organ involvement by alpha‐synuclein pathology in Lewy body disorders
2014
Recent advances in the histo‐molecular pathology of human prion disease
2018
MDS clinical diagnostic criteria for Parkinson's disease
2015 Standout
Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging study
2018
Plasma Neurofilament Light and Alzheimer’s Disease Biomarkers in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)
2019
A circadian gene expression atlas in mammals: Implications for biology and medicine
2014 Standout
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Neuropathology of prodromal Lewy body disease
2014
Migraine Attacks the Basal Ganglia
2011
A transcriptional signature of Alzheimer’s disease is associated with a metastable subproteome at risk for aggregation
2016
Cerebrospinal Fluid Markers of Alzheimer’s Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer’s Disease
2016
A rigorous method to enrich for exosomes from brain tissue
2017
Plasma tau in Alzheimer disease
2016 StandoutNobel
Smartphone motor testing to distinguish idiopathic REM sleep behavior disorder, controls, and PD
2018
Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer’s disease and other neurodegenerative diseases
2017
Parkinson risk in idiopathic REM sleep behavior disorder
2015
Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer’s Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks
2016
Sleep Health: An Opportunity for Public Health to Address Health Equity
2020
A Phase II Trial of Tideglusib in Alzheimer's Disease
2015
Are subjective cognitive complaints relevant in preclinical Alzheimer's disease? A review and guidelines for healthcare professionals
2012
Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Disease
2015
MRI-Based Screening of Preclinical Alzheimer’s Disease for Prevention Clinical Trials
2018
Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings
2015
α‐Synuclein oligomers and clinical implications for Parkinson disease
2012
APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern
2015
Works of Albert Lladó being referenced
CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration
2017
Variably protease‐sensitive prionopathy presenting within ALS/FTD spectrum
2018
Increased Cortical Thickness and Caudate Volume Precede Atrophy in PSEN1 Mutation Carriers
2010
Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
2018
Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study
2013
Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease
2014
Large APP locus duplication in a sporadic case of cerebral haemorrhage
2014
Cognitively Preserved Subjects with Transitional Cerebrospinal Fluid ß-Amyloid 1-42 Values Have Thicker Cortex in Alzheimer's Disease Vulnerable Areas
2011
CSF YKL-40 and pTau181 are related to different cerebral morphometric patterns in early AD
2015
Altered Blood Gene Expression of Tumor-Related Genes (PRKCB, BECN1, and CDKN2A) in Alzheimer’s Disease
2015
White matter changes in preclinical Alzheimer's disease: a magnetic resonance imaging-diffusion tensor imaging study on cognitively normal older people with positive amyloid β protein 42 levels
2014
Identifying Earlier Alzheimer’s Disease: Insights from the Preclinical and Prodromal Phases
2011
Clinical, Neuropathologic, and Biochemical Profile of the Amyloid Precursor Protein I716F Mutation
2009
Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration
2008
Memantine: Targeting glutamate excitotoxicity in Alzheimer's disease and other dementias
2005
Neurodegenerative Disorder Risk in Idiopathic REM Sleep Behavior Disorder: Study in 174 Patients
2014
Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease
2012
Screening for the LRRK2 G2019S and codon-1441 mutations in a pathological series of parkinsonian syndromes and frontotemporal lobar degeneration
2008
Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease
2011
Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer’s Disease: Potential and Limitations
2016
Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes
2004
Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A Multicenter Study in Spain
2014
Cerebrospinal Fluid Biomarkers and Memory Present Distinct Associations along the Continuum from Healthy Subjects to AD Patients
2011
The APOE ε4 genotype modulates CSF YKL‐40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2
2016
Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder
2017
Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease
2016
Structural Connectivity Alterations Along the Alzheimer’s Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and Tau
2018
Cerebrospinal Fluid Level of YKL-40 Protein in Preclinical and Prodromal Alzheimer's Disease
2014
A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer's disease
2013
Distinct Functional Activity of the Precuneus and Posterior Cingulate Cortex During Encoding in the Preclinical Stage of Alzheimer's Disease
2012